Zydus Lifesciences announced that it has received approval from Health Canada to market Liothyronine tablets, a therapeutic ...

Zydus Lifesciences announced that it has received a Notice of Compliance (NOC) from Health Canada for its generic Liothyronine tablets in 5 mcg and 25 mcg strengths.

Zydus Lifesciences received regulatory approvals from Health Canada for generic Liothyronine tablets and from the USFDA for ...

SAN DIEGO, Oct. 06, 2025 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) today announced that it will report third quarter 2025 financial results on Thursday, November 6, 2025 after ...

A new study from Boston University has found that surgery may be a better long-term treatment for people with hyperthyroidism ...

Families across England will benefit from enhanced early detection of Hereditary Tyrosinaemia Type 1 (HT1), a rare but treatable genetic disorder.

This multidisciplinary team consists of neurosurgeons, neuroradiologists, head and neck pathologists, cancer surgeons, and endoscopic neurorhinology skull base surgeons who are specialized ...

Hypothyroidism was associated with an increased risk for small intestinal bacterial overgrowth across sexes, age groups, and BMI categories.

The FPIs sold stocks worth approximately Rs 313.77 crore, according to provisional data from the National Stock Exchange. The DIIs stayed net buyers for the 29th session and bought stake worth Rs ...

The doctor's prescription for hormone balance isn't just about supplements. A healthy diet, some sun and adequate blood ...

Stocks like Bank of India, Metropolis Healthcare, Dilip Buildcon, LTIMindtree, Brigade Enterprises, Zydus Lifesciences, Coal ...

Thyroid cancer is the 12th most common cancer in the United States, affecting more than 44,000 patients in 2024. Most ...